Aion Therapeutic Statistics

Total Valuation

Aion Therapeutic has a market cap or net worth of CAD 7.25 million. The enterprise value is 9.68 million.

Market Cap	7.25M
Enterprise Value	9.68M

Important Dates

The next estimated earnings date is Monday, December 30, 2024.

Earnings Date	Dec 30, 2024
Ex-Dividend Date	n/a

Share Statistics

Aion Therapeutic has 483.55 million shares outstanding. The number of shares has increased by 131.73% in one year.

Current Share Class	n/a
Shares Outstanding	483.55M
Shares Change (YoY)	+131.73%
Shares Change (QoQ)	+11.19%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	n/a
Float	437.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.38
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.53
EV / Sales	12.06
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.20

Current Ratio	0.20
Quick Ratio	0.03
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-6.62

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-116.83%
Return on Capital (ROIC)	n/a
Revenue Per Employee	160,468
Profits Per Employee	-1.27M
Employee Count	5
Asset Turnover	1.17
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.55, so Aion Therapeutic's price volatility has been lower than the market average.

Beta (5Y)	0.55
52-Week Price Change	-50.00%
50-Day Moving Average	0.02
200-Day Moving Average	0.01
Relative Strength Index (RSI)	47.69
Average Volume (20 Days)	67,482

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Aion Therapeutic had revenue of CAD 802,339 and -6.33 million in losses. Loss per share was -0.02.

Revenue	802,339
Gross Profit	356,533
Operating Income	-1.28M
Pretax Income	-6.33M
Net Income	-6.33M
EBITDA	n/a
EBIT	-1.28M
Loss Per Share	-0.02

Full Income Statement

Balance Sheet

The company has 80,956 in cash and 2.50 million in debt, giving a net cash position of -2.42 million or -0.01 per share.

Cash & Cash Equivalents	80,956
Total Debt	2.50M
Net Cash	-2.42M
Net Cash Per Share	-0.01
Equity (Book Value)	-4.05M
Book Value Per Share	-0.01
Working Capital	-4.20M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.15M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	44.44%
Operating Margin	-159.40%
Pretax Margin	-788.87%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	-159.40%
FCF Margin	n/a

Dividends & Yields

Aion Therapeutic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-131.73%
Shareholder Yield	-131.73%
Earnings Yield	-123.62%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Aion Therapeutic has an Altman Z-Score of -37.05. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-37.05
Piotroski F-Score	n/a